---
title: "Organon to Present New Research on Access and Value at ISPOR 2026 | OGN Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286556635.md"
description: "Organon to Present New Research on Access and Value at ISPOR 2026 | OGN Stock News"
datetime: "2026-05-15T03:30:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286556635.md)
  - [en](https://longbridge.com/en/news/286556635.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286556635.md)
---

# Organon to Present New Research on Access and Value at ISPOR 2026 | OGN Stock News

Organon to Present New Research on Access and Value at ISPOR 2026 | OGN Stock News

### Related Stocks

- [OGN.US](https://longbridge.com/en/quote/OGN.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [Artiva says AB-101 plus rituximab posts 71% ACR50 response in refractory RA study](https://longbridge.com/en/news/286959967.md)
- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)
- [Eton Pharmaceuticals Q1 product sales rise driven by portfolio expansion](https://longbridge.com/en/news/286461579.md)
- [Legend Biotech Q1 Solid for Carvykti, Focus Shifts to In Vivo Pipeline, RBC Says](https://longbridge.com/en/news/286290495.md)
- [AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC](https://longbridge.com/en/news/286750290.md)